Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 10Active not recruiting 2Withdrawn 1Unknown 1Recruiting 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 23Gynecologic 4Gastrointestinal 4Other solid neoplasm 2Head & Neck 2Endocrine 2NET 1Genitourinary 1

Conditions

Prostatic Neoplasms 958Urinary Bladder Neoplasms 264Carcinoma, Renal Cell 251Kidney Neoplasms 146Carcinoma, Transitional Cell 130Breast Neoplasms 128Neoplasms 122Colorectal Neoplasms 97Ovarian Neoplasms 91Melanoma 86Carcinoma, Non-Small-Cell Lung 84Lung Neoplasms 81Neoplasm Metastasis 79Pancreatic Neoplasms 68Non-Muscle Invasive Bladder Neoplasms 68Uterine Cervical Neoplasms 58Stomach Neoplasms 55Head and Neck Neoplasms 51Squamous Cell Carcinoma of Head and Neck 47Endometrial Neoplasms 47Adenocarcinoma 46Esophageal Neoplasms 44Testicular Neoplasms 42Sarcoma 41Carcinoma, Hepatocellular 41Disease 33Triple Negative Breast Neoplasms 32Liver Neoplasms 30Colonic Neoplasms 29Metastatic Castration-resistant Prostate Cancer 25

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Recruiting × Thymoma × Genitourinary × Clear all
NCT07181720 2025-10-02

CD70-Targeted CAR-T Therapy in CD70-Positive Advanced Solid Tumors

Chongqing Precision Biotech Co., Ltd

Phase 1 Recruiting
90 enrolled
EndocrineGenitourinaryGynecologicHead & NeckThoracic

Carcinoma, Renal Cell, Uterine Cervical Neoplasms, Lung Neoplasms, Ovarian Neoplasms, Thymoma, Thyroid Carcinoma, Anaplastic

Data powered by HemOnc (CC BY 4.0) Colophon âš¡